Sign in
8-K

Current Report

Acrivon Therapeutics, Inc. Filed Acc 0001193125-26-455669

Regulation FD disclosure

  • Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Loading acrv-20261110.htm…